Coxevac
Coxevac is an inactivated phase 1 vaccine designed to protect against Q Fever.
Used in cattle to lower the risk of non-infected animals becoming shedders of Coxiella burnetii, and to reduce overall shedding on infected farms via milk, faeces and vaginal mucus.
In goats and sheep, to reduce abortion caused by Coxiella burnetii and to reduce shedding of the bacterium via milk, vaginal mucus, faeces and placenta.
Available in:
- 40 ml
Target species:
-
Cattle
-
Goat
-
Sheep
Product information
How to use
Dose: cattle 4mls, sheep & goats 2mls
- Suspension for subcutaneous injection, in the neck region
Can be administered from 3 months of age - Two doses should be given with an interval of 3 weeks as primary course and followed by a periodic booster
- Withdrawal: Cattle milk – zero hours, meat – zero days. Small ruminants: meat, milk and offal – zero days.
Prescription decisions are for the person issuing the prescription alone. Please refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications. Further information is available from the SPC or on the datasheet at www.noahcomendium.co.uk or on request.
Legal Category: POMV

Why choose
Coxevac?
Fewer abortions
Vaccinated cows are 30% less likely to abort when compared to unvaccinated herds1
Less shedding
Lowers the probability of an animal becoming a shedder by 5 times and reduces the shedding of C. burnetii2 decreasing the impact of the disease in the herd
Empowers the Immunity
Coxevac vaccine induces optimal cellular and humoral immune responses
Reduces environmental load
Whole herd vaccination reduces the bacterial load across the herd, reducing the environmental burden, so reducing the risk of other animals and humans being exposed to the pathogen3,4